Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update
Methodological detailsGRADE approach, guideline update
- GRADE approach
- Guideline update
Recommendations
As issued by the authors
Focus on preserving kidney function and maintaining well-being using a layered approach to care
Foundation of lifestyle interventions, self-management, and first-line pharmacotherapy (such as SGLT2i) demonstrated to improve clinical outcomes
Add drugs with heart and kidney protection, such as GLP-1 RA and nonsteroidal mineralocorticoid receptor antagonists
Add interventions to control risk factors for chronic kidney disease (CKD) progression and cardiovascular events, such as blood pressure, glycemia, and lipids
Original publication
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Ann Intern Med. Published 10 January 2023. doi:10. 7326/ m22-2904
Composed by AI from the published abstract and checked against it. How Briefs are made →